Skip to main content

CLC Bio, RainDance Partner on Tailored Software

NEW YORK (GenomeWeb News) – RainDance Technologies and CLC Bio will partner to develop software for analyzing targeted resequence data developed using RainDance's microdroplet technology, CLC Bio said today.

The software solution the companies develop will be interoperable with major next-generation sequencing systems, including ABI's SoLiD, Illumina's Genome Analyzer, and Roche/454 sequencers.

CLC Bio said that it first plans to expand its Genomics Workbench to enhance data analysis speed and efficacy when used with the RainDance RainStorm technology. The Danish firm said that in the future the partners plan to release specialized reports, data analyses, and workflow support for targeted resequencing research.

"Having decided to focus on high-throughput sequencing technologies several years ago, we're constantly monitoring the market to identify new and complimentary technologies being developed," CLB Bio CEO Thomas Knudsen said in a statement.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.